Medivation board rejects Sanofi's $9.3 billion takeover offer
Tweet
Share
E-mail
The Sanofi logo is seen at the company's Sanofi Pasteur headquarters in Lyon, France, October 26, 2015. French drugs firm Sanofi will present its Q3 results on October 29. REUTERS/Robert Pratta
Get Alerts MDVN Hot Sheet
Join SI Premium – FREE
(Reuters) - Medivation Inc (NASDAQ: MDVN) said on Friday its board rejected an unsolicited $9.3 billion takeover proposal from Sanofi SA
The French drugmaker went public with its $52.50 per share cash offer on Thursday. Medivation's shares were trading at $56.41 before market open on Friday.
"Our Board strongly believes that Medivation's business plan will deliver value to our stockholders that is far superior to Sanofi's offer and unanimously rejects your proposal," Medivation said in statement.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Saumyadeb Chakrabarty)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- European leaders pledge unity after recent tensions ahead of NATO summit
- US military requires flu vaccine for some after outbreak in Texas training center
- Rubio says U.S. won't do anything that would undermine Gulf security
Create E-mail Alert Related Categories
ReutersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
